Société Algérienne des Affaires Réglementaires et de Pharmaco-économie

Informations de contact, plan et itinéraire, formulaire de contact, heures d'ouverture, services, évaluations, photos, vidéos et annonces de Société Algérienne des Affaires Réglementaires et de Pharmaco-économie, Algiers.

The Algerian Society for Regulatory Affairs & Pharmacoeconomics (SAARPE) is a non-profit scientific organization, created in Algiers on 26th of October 2015, under the provisions of the Law No. 12-06 related to Associations. La SAARPE

SOCIETE ALGERIENNE DES AFFAIRES REGLEMENTAIRES ET DE PHARMACO-ECONOMIE est une association nationale savante à but non lucratif comptant parmi ses membres, pour ne

08/12/2020

Global equitable access to vaccines in low- and lower-middle-income countries has been estimated to generate economic benefits of at least US$ 153bn in 2020–21, and US$ 466bn by 2025, in 10 major economies (Canada, France, Germany, Japan, Qatar, South Korea, Sweden, UAE, UK and USA), according to Eurasia Group's new report commissioned by the Bill & Melinda Gates Foundation.

This is more than 12 times the US$ 38bn estimated total cost of the Access to COVID-19 Tools (ACT) Accelerator, led by WHO, and aiming to support the development and equitable distribution of the tests, treatments and vaccines the world needs to fight COVID-19.

Read more: https://www.who.int/news/item/03-12-2020-global-access-to-covid-19-vaccines-estimated-to-generate-economic-benefits-of-at-least-153-billion-in-2020-21

Photos from Société Algérienne des Affaires Réglementaires et de Pharmaco-économie's post

06/12/2020

: Official decrees defining conditions for granting Marketing Authorization related to Drug and Medical Devices, as well as Inter-Ministerial Pricing Committee organization and functioning rules have just been published in the Official Gazette No 69 dated of November 22nd, 2020.

05/12/2020

The first COVID-19 vaccine for the UK, developed by Pfizer/BioNTech, has today been given approval for use following a thorough a "rolling review" carried out by the Medicines and Healthcare products Regulatory Agency (MHRA).

Read more: https://www.gov.uk/government/news/uk-medicines-regulator-gives-approval-for-first-uk-covid-19-vaccine

26/11/2020

Interested by regulatory affairs and/or health economics fields? Join the SAARPE today, and receive a complementary hard copy of "The Pharma Legal Handbook Algeria".

Vous êtes intéressés par le domaine des affaires réglementaires et/ou de l’économie de santé ? Rejoignez la SAARPE dès aujourd’hui et recevez un exemplaire gratuit de l’ouvrage "The Pharma Legal Handbook Algeria".

Membership form/Formulaire d’adhésion:
https://s.surveyplanet.com/xqaQEO-NW

25/11/2020

Today, the European Commission (EC) has adopted its Pharmaceutical Strategy for Europe: https://ec.europa.eu/health/human-use/strategy_en

The aforementioned strategy is based on four specific pillars, which include legislative and non-legislative action:

1- Ensuring access to affordable medicines for patients, and addressing unmet medical needs (e.g. in the areas of antimicrobial resistance, rare diseases);

2- Supporting competitiveness, innovation and sustainability of the EU’s pharmaceutical industry and the development of high quality, safe, effective and greener medicines;

3- Enhancing crisis preparedness and response mechanisms, diversified and secure supply chains, address medicines shortages;

4- Ensuring a strong EU voice in the world, by promoting a high level of quality, efficacy and safety standards.

12/11/2020

To all Virtual ISPOR Europe 2020 registered attendees, don't miss the ISPOR Arabic Network's Discussion Group exploring the "Effect of Public and Private Partnership in Healthcare Financing to Improve Health Outcomes"...

Link to the 1-hour pre-recorded session (released today): https://lnkd.in/eKHp-wj

Link to join the 1-hour live discussion (November 17, 2020: 18:15-19:15 CET): https://lnkd.in/eU-2ZaT

Group Discussions are a new, two-part content type for ISPOR events: an on demand, pre-recorded session to be released before the live conference dates, and a follow-up hour-long live discussion during the live conference dates. The expectation for attendees is that they watch the on-demand content before the meeting, and then participate in a live discussion of the on-demand sessions during the conference.

25/10/2020

"PHARMACIST FORUM" [Invitation].
Topic: Health Technology Assessment & Budget Impact Analysis.
Date: Saturday, October 10th, 2020.
Time: 16:00-18:00 (GMT+1).
Language: French.
Link for registration: https://us02web.zoom.us/webinar/register/WN_AS1jsBgpTKybUd8LFrZPCQ

19/10/2020

"PHARMACIST FORUM" [Invitation].
Topic: Innovative Pharma Contracting.
Date: Saturday, October 24th, 2020.
Time: 16:00-17:30 (GMT+1).
Language: French.
Link for registration: https://us02web.zoom.us/webinar/register/WN_zsSPCPIAR9SMgeT2RMhyqA

14/10/2020

"PHARMACIST FORUM" [Invitation].
Topic: Pharmacovigilance, Biologics & Biosimilars.
Date: Saturday, October 17th, 2020.
Time: 16:00-18:00 (GMT+1).
Language: French.

Link for registration: https://us02web.zoom.us/webinar/register/WN_48RdUrgcRR61PfUZXuKR8Q

14/10/2020

Réunion du gouvernement: examen de projets de décrets exécutifs concernant plusieurs secteurs ALGER - Le Premier ministre, Abdelaziz Djerad, a présidé mercredi par visioconférence une réunion du Gouvernement durant laquelle ont été examinés des...